title: Characterization of the binding of Bolton-Hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes.
abstract: The fifth component of the complement cascade, C5a, was iodinated using the Bolton-Hunter reagent. Results from the present study, using the high affinity ligand, [125I]Bolton-Hunter-labeled C5a ([125I]BH-C5a), revealed a single binding site on membranes prepared from human neutrophils, U-937 cells and human monocytes. Saturation studies demonstrated Bmax values in these cells of 11.5, 47.3 and 16.6 fmol/10(6) cells, respectively. The C5a receptor demonstrated a very high affinity for [125I]BH-C5a of approximately 4 pM in each cell type. Competition studies using analogs of C5a generated a similar order of potency in each of the cell types of C5a > or = C5a(1-74), Ser66Ala > C5a(1-73) > C5a(1-69). These studies indicate that [125I]BH-C5a labels a similar receptor in neutrophil, U-937 cell and monocyte membranes. Furthermore, C5a(1-73) produced shallow inhibition curves in competition experiments in each cell type. Computer analysis of the binding data revealed two components of binding. When 10 nM unlabeled C5a was used to initiate dissociation of [125I]BH-C5a binding in neutrophil membranes, two binding components were observed. In addition, dissociation of [125I]BH-C5a binding by 10 nM unlabeled C5a in the presence of 1 mM GppNHp decreased the percentage of binding to the slowly dissociating, high affinity binding component from 84 to 58%. These results suggest that multiple states of the C5a receptor exist.
authors.affiliation: CIBA-GEIGY Corporation, Research Department, Summit, NJ 07901.
authors.forename: A F
authors.initials: AF
authors.lastname: Braunwalder
authors.forename: D
authors.initials: D
authors.lastname: Musmanno
authors.forename: N
authors.initials: N
authors.lastname: Galakatos
authors.forename: R H
authors.initials: RH
authors.lastname: Garlick
authors.forename: W O
authors.initials: WO
authors.lastname: Haston
authors.forename: J J
authors.initials: JJ
authors.lastname: Rediske
authors.forename: L
authors.initials: L
authors.lastname: Wennogle
authors.forename: B
authors.initials: B
authors.lastname: Seligmann
authors.forename: M A
authors.initials: MA
authors.lastname: Sills
mesh_terms: D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D015936:Complement C5a / Q000378:metabolism*; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D006801:Humans; D008024:Ligands; D009000:Monocytes / Q000166:cytology*; D009504:Neutrophils / Q000166:cytology*; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D013388:Succinimides; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D008024:Ligands; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D011994:Recombinant Proteins; D013388:Succinimides; D006165:Guanylyl Imidodiphosphate; C022581:Bolton-Hunter reagent; D015936:Complement C5a; D002118:Calcium